Stock Quote & Chart

Stock Quote

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Historical Price Lookup

Week of November 29, 2021

Date Requested: November 29, 2021
Closing Price
$8.85
Volume
252,147
Split Adjustment Factor
1:1
Open Price
$9.47
Day High
$9.50
Day Low
$8.80
Date Requested: November 30, 2021
Closing Price
$8.95
Volume
586,291
Split Adjustment Factor
1:1
Open Price
$8.95
Day High
$9.15
Day Low
$8.50
Date Requested: December 1, 2021
Closing Price
$8.62
Volume
276,693
Split Adjustment Factor
1:1
Open Price
$9.21
Day High
$9.31
Day Low
$8.59
Date Requested: December 2, 2021
Closing Price
$9.20
Volume
265,802
Split Adjustment Factor
1:1
Open Price
$8.62
Day High
$9.24
Day Low
$8.44
Date Requested: December 3, 2021
Closing Price
$8.83
Volume
437,825
Split Adjustment Factor
1:1
Open Price
$9.19
Day High
$9.24
Day Low
$8.73

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of future price performance.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Analysts
Firm Analyst
Bank of America Merrill Lynch
Tazeen Ahmad
Canaccord Genuity
Arlinda Lee, Ph.D.
Cowen and Company
Phil Nadeau, Ph.D.
Goldman Sachs
Corinne Jenkins
Ladenburg Thalmann & Co.
Michael Higgins
Morgan Stanley
Jeff Hung
Needham & Company
Joseph Stringer, Ph.D.

Rhythm Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Rhythm Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Rhythm Pharmaceuticals, Inc. or its management. Rhythm Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.